CN110664955A - A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application - Google Patents

A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application Download PDF

Info

Publication number
CN110664955A
CN110664955A CN201911096698.0A CN201911096698A CN110664955A CN 110664955 A CN110664955 A CN 110664955A CN 201911096698 A CN201911096698 A CN 201911096698A CN 110664955 A CN110664955 A CN 110664955A
Authority
CN
China
Prior art keywords
root
hyperosteogeny
rheumatoid arthritis
radix
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201911096698.0A
Other languages
Chinese (zh)
Inventor
张金生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201911096698.0A priority Critical patent/CN110664955A/en
Publication of CN110664955A publication Critical patent/CN110664955A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237—Notopterygium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A61K36/515—Gentiana
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis, a preparation method and application thereof, belonging to the technical field of traditional Chinese medicines, and the traditional Chinese medicine composition comprises the following components: red ginseng, astragalus, pangolin scales, large-leaved gentian, honeysuckle stem, Chinese starjasmine stem, caulis sinomenii, caulis spatholobi, white paeony root, prepared rhizome of rehmannia, cassia twig, rhizoma cimicifugae, herba siegesbeckiae, herba lycopi, notopterygium root, radix angelicae pubescentis, eucommia bark, radix sileris, rhizoma corydalis, mulberry twig, safflower, dragon's blood, pseudo-ginseng, obscured homalomena rhizome, aniseed, pine knot, sea cucumber, tall gastrodia tuber, prepared radix aconiti, prepared kusnezoff monkshood root, tuber fleeceflower root, pawpaw, medicinal cyathula root, clematis root, pinellia tuber, galangal, long. The traditional Chinese medicine composition has obvious curative effects on lumbar disc herniation, rheumatoid arthritis, various hyperosteogeny, tenosynovitis and other diseases, has small side effects, mainly has gastrointestinal tract reaction, does not relapse after healing, has an average cure rate of 92 percent and an average effective rate of 97.3 percent.

Description

A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis, and a preparation method and application thereof.
Background
The main cause of treating the protrusion of the lumbar intervertebral disc is each part of the lumbar intervertebral disc, such as: nucleus pulposus, annulus fibrosus and the cartilage plate. Especially, the nucleus pulposus has degenerative changes of different degrees, under the action of external force factors, the annulus fibrosus of the intervertebral disc is ruptured, and the nucleus pulposus tissue protrudes or is extruded from the ruptured part at the back, so that the adjacent spinal nerve roots are stimulated or pressed, and a series of clinical symptoms such as waist pain, numbness and pain of one lower limb or two lower limbs are generated.
Hyperosteogeny is a normal degeneration phenomenon of human body aging, so that at a certain age, everyone can have hyperosteogeny of different degrees in joints with more activities and larger load, such as cervical vertebra, knee joint, lumbar vertebra and the like to form spine-shaped or lip-shaped hyperosteogeny, and the bone spurs can mechanically stimulate and traumatize soft tissues, such as soft tissue injury, bleeding and swelling.
Rheumatoid arthritis is a common acute or chronic inflammation of the connective tissue. Generally, the rheumatic arthritis is one of the main manifestations of rheumatic fever, and is clinically characterized by joint and muscle wandering soreness, red swelling and pain. Joint pain is the primary symptom of rheumatoid arthritis, and pain may occur in joints of the whole body, but is more commonly suffered from large joints, such as knee joints, ankle joints, shoulder joints, wrist joints and the like. Typically, it is manifested as symmetrical, migratory pain, and inflammation accompanied by redness, swelling, and heat. Usually, the acute inflammation symptoms disappear after 2-4 weeks, one joint symptom disappears, the other joint symptom appears again, and several joints are attacked at the same time.
The existing medicines for treating the lumbar intervertebral disc protrusion, the hyperosteogeny and the rheumatoid arthritis are single, and the medicines for treating the root cause are relatively few and have more side effects.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis. The traditional Chinese medicine composition comprises the following components: red ginseng, astragalus, pangolin scales, large-leaved gentian, honeysuckle stem, Chinese starjasmine stem, caulis sinomenii, caulis spatholobi, white paeony root, prepared rhizome of rehmannia, cassia twig, rhizoma cimicifugae, herba siegesbeckiae, herba lycopi, notopterygium root, radix angelicae pubescentis, eucommia bark, radix sileris, rhizoma corydalis, mulberry twig, safflower, dragon's blood, pseudo-ginseng, obscured homalomena rhizome, aniseed, pine knot, sea cucumber, tall gastrodia tuber, prepared radix aconiti, prepared kusnezoff monkshood root, tuber fleeceflower root, pawpaw, medicinal cyathula root, clematis root, pinellia tuber, galangal, long.
Preferably, the traditional Chinese medicine composition comprises the following components in parts by weight: 10-20g of red ginseng, 10-30g of astragalus membranaceus, 10-20g of pangolin scales, 10-20g of gentiana macrophylla, 10-20g of honeysuckle stem, 10-20g of Chinese starjasmine stem, 10-20g of caulis sinomenii, 10-20g of caulis spatholobi, 10-20g of radix paeoniae alba, 10-20g of radix rehmanniae preparata, 10-20g of cassia twig, 10-20g of rhizoma cimicifugae, 10-20g of herba siegesbeckiae, 10-20g of herba lycopi, 10-20g of notopterygium root, 5-25g of radix angelicae pubescentis, 5-25g of eucommia bark, 10-20g of radix sileris, 5-25g of rhizoma corydalis, 5-25g of ramulus mori, 10-20g of safflower carthamus, 10-20g of dragon's blood, 5-25g of pseudo-ginseng, 10-20g of obscured homalomena rhizome, 10-20g of anisetree, 5-15g of prepared common monkshood mother root, 5-15g of prepared kusnezoff monkshood root, 10-20g of tuber fleeceflower root, 10-20g of pawpaw, 10-20g of medicinal cyathula root, 10-20g of clematis root, 10-20g of pinellia tuber, 10-20g of lesser galangal rhizome, 10-20g of long-noded pit viper, 5-25g of szechuan lovage rhizome, 5-15g of mix-fried ephedra herb, 5-25g of largehead atractylodes rhizome, 5-25g of poria and 10-20.
Further preferably, the traditional Chinese medicine composition comprises the following components in parts by weight: 10g of red ginseng, 20g of astragalus membranaceus, 10g of pangolin scales, 10g of large-leaved gentian, 10g of honeysuckle stem, 10g of Chinese starjasmine stem, 10g of caulis sinomenii, 10g of caulis spatholobi, 10g of white peony root, 10g of prepared rhizome of rehmannia, 10g of cassia twig, 10g of cimicifugae foetidae, 10g of herba siegesbeckiae, 10g of herba lycopi, 10g of notopterygium root, 15g of radix angelicae pubescentis, 15g of eucommia ulmoides, 10g of radix sileris, 15g of rhizoma corydalis, 15g of mulberry twig, 10g of safflower, 10g of dragon's blood, 15g of pseudo-ginseng, 10g of obscured homalomena rhizome, 10g of cortex illicii, 10g of lignum pini, 10g of rhizoma gastrodiae, 5g of prepared radix aconiti agrestis feriae, 10g of polygonum multiflorum, 10 g.
Preferably, the dosage form of the traditional Chinese medicine composition is pills.
Further preferably, the weight of the pill is 5g per pill.
A preparation method of a Chinese medicinal composition for treating lumbar disc herniation, hyperostosis and rheumatoid arthritis comprises the following steps: grinding the raw materials into powder, mixing, and making into pill or watered pill to obtain oral pill.
The invention also aims to protect the application of the traditional Chinese medicine composition in treating lumbar disc herniation, hyperosteogeny, rheumatoid arthritis and tenosynovitis.
The invention has the beneficial effects that: has obvious curative effect on lumbar disc herniation, rheumatoid arthritis, various hyperosteogeny, tenosynovitis and other diseases, has small side effect, mainly has gastrointestinal tract reaction, does not relapse after healing, has the average cure rate of 92 percent and the average effective rate of 97.3 percent.
Detailed Description
The following describes embodiments of the present invention in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
A traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis comprises the following components by weight: 10g of red ginseng, 20g of astragalus membranaceus, 10g of pangolin scales, 10g of large-leaved gentian, 10g of honeysuckle stem, 10g of Chinese starjasmine stem, 10g of caulis sinomenii, 10g of caulis spatholobi, 10g of white peony root, 10g of prepared rhizome of rehmannia, 10g of cassia twig, 10g of cimicifugae foetidae, 10g of herba siegesbeckiae, 10g of herba lycopi, 10g of notopterygium root, 15g of radix angelicae pubescentis, 15g of eucommia ulmoides, 10g of radix sileris, 15g of rhizoma corydalis, 15g of mulberry twig, 10g of safflower, 10g of dragon's blood, 15g of pseudo-ginseng, 10g of obscured homalomena rhizome, 10g of cortex illicii, 10g of lignum pini, 10g of rhizoma gastrodiae, 5g of prepared radix aconiti agrestis feriae, 10g of polygonum multiflorum, 10 g.
The preparation method of the traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis in the embodiment comprises the following steps: grinding the raw materials into powder, mixing, and refining into pills, wherein each pill weighs 5g to obtain the oral pills.
The using method comprises the following steps: the pill is taken 1 pill each time, three times a day, half an hour after meals, 30 days as a course of treatment, and 2-3 courses of continuous administration.
Example 2
A traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis comprises the following components by weight: 15g of red ginseng, 10g of astragalus membranaceus, 15g of pangolin scales, 15g of large-leaved gentian, 15g of honeysuckle stem, 15g of Chinese starjasmine stem, 15g of caulis sinomenii, 15g of caulis spatholobi, 15g of white peony root, 15g of prepared rehmannia root, 15g of cassia twig, 15g of cimicifugae foetidae, 15g of herba siegesbeckiae, 15g of herba lycopi, 5g of notopterygium root, 5g of radix angelicae pubescentis, 15g of eucommia ulmoides, 15g of radix sileris, 5g of rhizoma corydalis, 5g of mulberry twig, 15g of safflower, 15g of dragon's blood, 5g of pseudo-ginseng, 15g of obscured homalomena rhizome, 15g of cortex illicii, 15g of pine nodular branch of pine, 15g of rhizoma gastrodiae, 10g of prepared radix aconiti feriae, 15g of polygonum multiflorum, 15g of paw.
The preparation method of the traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis in the embodiment comprises the following steps: grinding the raw materials into powder, mixing, and refining into pills, wherein each pill weighs 5g to obtain the oral pills.
The using method comprises the following steps: the pill is taken 1 pill each time, three times a day, half an hour after meals, 30 days as a course of treatment, and 2-3 courses of continuous administration.
Example 3
A traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis comprises the following components by weight: 20g of red ginseng, 10g of astragalus membranaceus, 20g of pangolin scales, 20g of large-leaved gentian, 20g of honeysuckle stem, 20g of Chinese starjasmine stem, 20g of caulis sinomenii, 20g of caulis spatholobi, 20g of white peony root, 20g of prepared rehmannia root, 20g of cassia twig, 20g of cimicifugae foetidae, 20g of herba siegesbeckiae, 20g of herba lycopi, 20g of notopterygium root, 25g of radix angelicae pubescentis, 25g of eucommia ulmoides, 20g of radix sileris, 25g of rhizoma corydalis, 25g of mulberry twig, 20g of safflower carthamus, 10g of dragon's blood, 25g of pseudo-ginseng, 20g of obscured homalomena rhizome, 20g of anisetree, 20g of pine nodular branch of pine, 20g of rhizoma gastrodiae, 15g of prepared monkshood, 15g of prepared kusnezoff monkshood root, 20g of polygonum multiflorum, 20.
The preparation method of the traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis in the embodiment comprises the following steps: grinding the raw materials into powder, mixing, and refining into pills, wherein each pill weighs 5g to obtain the oral pills.
The using method comprises the following steps: the pill is taken 1 pill each time, three times a day, half an hour after meals, 30 days as a course of treatment, and 2-3 courses of continuous administration.
Example 4
A traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis comprises the following components by weight: 12g of red ginseng, 15g of astragalus membranaceus, 12g of pangolin scales, 12g of gentiana macrophylla, 12g of honeysuckle stem, 12g of Chinese starjasmine stem, 12g of caulis sinomenii, 12g of caulis spatholobi, 12g of radix paeoniae alba, 12g of radix rehmanniae preparata, 12g of cassia twig, 12g of rhizoma cimicifugae, 12g of herba siegesbeckiae, 12g of herba lycopi, 12g of notopterygium root, 10g of radix angelicae pubescentis, 10g of eucommia ulmoides, 12g of radix sileris, 10g of rhizoma corydalis, 10g of mulberry twig, 12g of safflower, 12g of dragon's blood, 10g of pseudo-ginseng, 12g of obscured homalomena rhizome, 12g of cortex illicii, 12g of lignum pinelliae, 12g of square sea, 12g of rhizoma gastrodiae, 7g of prepared radix aconiti agrestis feriae, 12g of polygonum multiflo.
The preparation method of the traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis in the embodiment comprises the following steps: grinding the raw materials into powder, mixing, and refining into pills, wherein each pill weighs 5g to obtain the oral pills.
The using method comprises the following steps: the pill is taken 1 pill each time, three times a day, half an hour after meals, 30 days as a course of treatment, and 2-3 courses of continuous administration.
Example 5
A traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis comprises the following components by weight: 17g of red ginseng, 25g of astragalus membranaceus, 17g of pangolin scales, 17g of gentiana macrophylla, 17g of honeysuckle stem, 17g of Chinese starjasmine stem, 17g of caulis sinomenii, 17g of caulis spatholobi, 17g of radix paeoniae alba, 17g of radix rehmanniae preparata, 17g of cassia twig, 17g of rhizoma cimicifugae, 17g of herba siegesbeckiae, 17g of herba lycopi, 17g of notopterygium root, 20g of radix angelicae pubescentis, 20g of eucommia ulmoides, 17g of radix sileris, 20g of rhizoma corydalis, 20g of mulberry twig, 17g of safflower, 17g of dragon's blood, 20g of pseudo-ginseng, 17g of obscured homalomena rhizome, 17g of cortex illicii, 17g of lignum pini, 17g of square sea cucumber, 17g of rhizoma gastrodiae, 12g of radix aconiti preparata, 12g of prepared kusnezoffii, 17g of polygonum multiflorum, 17.
The preparation method of the traditional Chinese medicine composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis in the embodiment comprises the following steps: grinding the raw materials into powder, mixing, and refining into pills, wherein each pill weighs 5g to obtain the oral pills.
The using method comprises the following steps: the pill is taken 1 pill each time, three times a day, half an hour after meals, 30 days as a course of treatment, and 2-3 courses of continuous administration.
Examples of the experiments
Clinical trial
1. Selection of test examples
150 patients with confirmed lumbar disc herniation were selected, 75 patients (50%) male and 75 patients (50%) female. Age 24-62 years, mean 43 years, medical history 2-3 years, 150 cases were randomized into three groups, one treatment, two and three, 50 cases each.
The age, the course of disease and the degree of severity of symptoms of the three groups of cases are basically consistent, have no obvious difference and are comparable.
2. Drug selection
A group of pills taking the traditional Chinese medicine composition obtained in the embodiment 1 of the invention are taken orally three times a day, 1 pill is taken each time, one treatment course is 30 days, and 3 treatment courses are continuously taken.
The two groups of pills are orally taken, 1 pill is taken three times a day, 30 days are taken as a treatment course, and 3 treatment courses are continuously taken.
Three groups of pills of the traditional Chinese medicine composition obtained in the embodiment 3 of the invention are taken orally three times a day, 1 pill is taken each time, one treatment course is 30 days, and 3 treatment courses are continuously taken.
3. Criteria for judging therapeutic effects
And (3) excellent: the symptoms and physical signs disappear, and the normal work is recovered.
Good: the patient can recover from the pain.
Can be as follows: the symptoms are improved, but the pain still exists, and the work can be done well.
Difference: symptoms and signs are not improved.
4. Therapeutic results
Treatment one to three groups were treated for 3 courses with the following treatment results:
one group of treatments was: the total 50 cases show that the curative effect reaches 44 cases with excellent curative effect, 2 cases with excellent curative effect can be obtained, and 1 case with poor curative effect is obtained, namely the cure rate is 88 percent, and the effective rate is 98 percent.
Two groups of treatments were: the curative effect reaches 46 cases with excellent curative effect, 3 cases with excellent curative effect can reach 1 case with 1 case difference, namely the cure rate is 92 percent, and the effective rate is 98 percent.
Three groups were treated: the curative effect reaches 48 cases with excellent curative effect in 50 cases, and can reach 2 cases. The cure rate is 96 percent, and the effective rate is 96 percent.
The average cure rate is 92 percent, and the average effective rate is 97.3 percent.
Clinical cases
In case 1, a certain Liu is suffered from lumbar intervertebral disc protrusion, lumbago and leg pain in 2017 for 4 months, sciatica symptoms appear and cannot walk, the pain is relieved by taking the pill of the embodiment 1 for 10 days, 1 half month of treatment can walk, clinical symptoms disappear after taking the pill for 3 months, and curative effect is consolidated after taking the pill for two months, so far, the disease does not relapse.
In case 2, a certain wang is a male, the male is 45 years old, the working reason is long-term sitting and the sitting posture is poor, the lumbar intervertebral disc protrusion is suffered, standing is often painful, normal standing activities cannot be realized, various traditional Chinese and western medicine treatments are carried out in the first half of 2018, the lumbar intervertebral disc protrusion cannot be cured, the pain is relieved after the pill of the embodiment 2 is taken for 1 month, clinical symptoms disappear after 6 treatments, the curative effect is consolidated after the pill is taken for two months, and the lumbar intervertebral disc protrusion does not relapse until now.
Case 3, in male, 35 years old, pain in the lower half of the body, which was difficult to endure by self-administration of pain-relieving drugs in the early stage, was diagnosed as rheumatoid arthritis. After taking the pill of the embodiment 3 for 1 month, the pain is relieved, the clinical symptoms disappear after 10 treatments, and the curative effect is consolidated after taking the pill for two months, so far, the recurrence is not caused.
In case 4, male is 29 years old and overweight, the left forefoot is usually used for exerting force while walking, the left forefoot is usually painful, and the tenosynovitis is diagnosed and treated as nosocomial tenosynovitis. After taking the pill of the embodiment 4 for 1 month, the pain is relieved, the clinical symptoms disappear after 3 treatments, and the curative effect is consolidated after taking the pill for two months, so far, the recurrence is not caused.
In case 5, a man is aged 56 years old, long-term fatigue and difficult waist pain occur, the patients are diagnosed as lumbar hyperplasia and lumbar disc herniation, after taking the pill of the embodiment 5 for 1 month, the symptoms are obviously relieved, half-year symptoms disappear, and after the patients are cooled by fatigue, the pill is taken again and again, and the symptoms are relieved in two or three months.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.

Claims (7)

1. A Chinese medicinal composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis is characterized in that: the traditional Chinese medicine composition comprises the following components: red ginseng, astragalus, pangolin scales, large-leaved gentian, honeysuckle stem, Chinese starjasmine stem, caulis sinomenii, caulis spatholobi, white paeony root, prepared rhizome of rehmannia, cassia twig, rhizoma cimicifugae, herba siegesbeckiae, herba lycopi, notopterygium root, radix angelicae pubescentis, eucommia bark, radix sileris, rhizoma corydalis, mulberry twig, safflower, dragon's blood, pseudo-ginseng, obscured homalomena rhizome, aniseed, pine knot, sea cucumber, tall gastrodia tuber, prepared radix aconiti, prepared kusnezoff monkshood root, tuber fleeceflower root, pawpaw, medicinal cyathula root, clematis root, pinellia tuber, galangal, long.
2. The Chinese medicinal composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis according to claim 1, wherein: the traditional Chinese medicine composition comprises the following components in parts by weight: 10-20g of red ginseng, 10-30g of astragalus membranaceus, 10-20g of pangolin scales, 10-20g of gentiana macrophylla, 10-20g of honeysuckle stem, 10-20g of Chinese starjasmine stem, 10-20g of caulis sinomenii, 10-20g of caulis spatholobi, 10-20g of radix paeoniae alba, 10-20g of radix rehmanniae preparata, 10-20g of cassia twig, 10-20g of rhizoma cimicifugae, 10-20g of herba siegesbeckiae, 10-20g of herba lycopi, 10-20g of notopterygium root, 5-25g of radix angelicae pubescentis, 5-25g of eucommia bark, 10-20g of radix sileris, 5-25g of rhizoma corydalis, 5-25g of ramulus mori, 10-20g of safflower carthamus, 10-20g of dragon's blood, 5-25g of pseudo-ginseng, 10-20g of obscured homalomena rhizome, 10-20g of anisetree, 5-15g of prepared common monkshood mother root, 5-15g of prepared kusnezoff monkshood root, 10-20g of tuber fleeceflower root, 10-20g of pawpaw, 10-20g of medicinal cyathula root, 10-20g of clematis root, 10-20g of pinellia tuber, 10-20g of lesser galangal rhizome, 10-20g of long-noded pit viper, 5-25g of szechuan lovage rhizome, 5-15g of mix-fried ephedra herb, 5-25g of largehead atractylodes rhizome, 5-25g of poria and 10-20.
3. The Chinese medicinal composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis according to claim 2, wherein: the traditional Chinese medicine composition comprises the following components in parts by weight: 10g of red ginseng, 20g of astragalus membranaceus, 10g of pangolin scales, 10g of large-leaved gentian, 10g of honeysuckle stem, 10g of Chinese starjasmine stem, 10g of caulis sinomenii, 10g of caulis spatholobi, 10g of white peony root, 10g of prepared rhizome of rehmannia, 10g of cassia twig, 10g of cimicifugae foetidae, 10g of herba siegesbeckiae, 10g of herba lycopi, 10g of notopterygium root, 15g of radix angelicae pubescentis, 15g of eucommia ulmoides, 10g of radix sileris, 15g of rhizoma corydalis, 15g of mulberry twig, 10g of safflower, 10g of dragon's blood, 15g of pseudo-ginseng, 10g of obscured homalomena rhizome, 10g of cortex illicii, 10g of lignum pini, 10g of rhizoma gastrodiae, 5g of prepared radix aconiti agrestis feriae, 10g of polygonum multiflorum, 10 g.
4. The Chinese medicinal composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis according to any one of claims 1 to 3, wherein: the Chinese medicinal composition is in the form of pills.
5. The Chinese medicinal composition for treating lumbar disc herniation, hyperosteogeny and rheumatoid arthritis according to claim 4, wherein: the weight of each pill is 5 g.
6. The method of preparing a Chinese medicinal composition for the treatment of lumbar disc herniation, hyperosteogeny and rheumatoid arthritis according to any one of claims 1 to 3, wherein the method comprises the following steps: the preparation method comprises the following steps: grinding the raw materials into powder, mixing, and making into pill or watered pill to obtain oral pill.
7. The use of the Chinese medicinal composition of any one of claims 1-3 for the treatment of lumbar disc herniation, hyperosteogeny, rheumatoid arthritis, and tenosynovitis.
CN201911096698.0A 2019-11-11 2019-11-11 A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application Withdrawn CN110664955A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911096698.0A CN110664955A (en) 2019-11-11 2019-11-11 A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911096698.0A CN110664955A (en) 2019-11-11 2019-11-11 A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application

Publications (1)

Publication Number Publication Date
CN110664955A true CN110664955A (en) 2020-01-10

Family

ID=69087161

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911096698.0A Withdrawn CN110664955A (en) 2019-11-11 2019-11-11 A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application

Country Status (1)

Country Link
CN (1) CN110664955A (en)

Similar Documents

Publication Publication Date Title
CN103893702A (en) Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof
CN104758659A (en) Traditional Chinese medicine paste for treating muscle and bone diseases
CN101966238A (en) Medicament for treating sciatica and preparation method thereof
CN102266542B (en) Ointment patch for treating hyperosteogeny and preparation method thereof
CN101703662A (en) Oral Chinese medicament for treating hyperosteogeny
CN111297997A (en) Oral Chinese medicinal composition for treating bone diseases and preparation method thereof
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN101433698B (en) Chinese medicament preparation for reunion of bone
CN100490880C (en) Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
CN108310217A (en) Zhuanggu medicinal liquor and production method
CN104383166A (en) Medicine for treating rheumatic lumbocrural pains and preparation method thereof
CN110664955A (en) A Chinese medicinal composition for treating lumbar intervertebral disc prolapse, hyperosteogeny and rheumatic arthritis, and its preparation method and application
CN105663913A (en) Traditional Chinese medicine composition for treating lumbar disc herniation
CN102512560A (en) Traditional Chinese medicinal composition for treating arthromyodynia
CN112755164A (en) Traditional Chinese medicine composition for strengthening tendons and bones, preparation and application thereof
CN102008666B (en) Drug for treating lumbocrural pain
CN108785421B (en) A Chinese medicinal composition for treating fracture and its preparation method
CN110946970A (en) Medicine for promoting reunion of fractured bones
CN104013734A (en) Traditional Chinese medicine oral liquid for treating osteoarthritis
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN110538272A (en) swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof
CN104173934A (en) Traditional Chinese medicine composition for treating sciatica
CN106924673A (en) A kind of Chinese medicine composition for treating osteoproliferation and its medicament preparation method
CN102028810B (en) Traditional Chinese medicine for treating lumbar intervertebral disc protrusion
CN100536895C (en) Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20200110

WW01 Invention patent application withdrawn after publication